DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in DICE Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- +30 vs. Q3 2022
- Shares held
- 47.5M
- +10.6M (+28.7%) vs. Q3 2022
- Total value
- $1.48B
- +$732.7M (+97.9%) vs. Q3 2022
- New holders
- 42
- 44 more added
- Sold out
- 12
- 20 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DICE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 160 | $2.12B |
| Q1 2023 | 115 | $1.49B |
| Q4 2022 | 109 | $1.48B |
| Q3 2022 | 79 | $748.2M |
| Q2 2022 | 80 | $564.6M |
| Q1 2022 | 76 | $637.5M |
| Q4 2021 | 69 | $799.4M |
| Q3 2021 | 39 | $793.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding DICE Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,903,416 | $59.4M | 0.00% | +516,658+37.3% | Added |
| Driehaus Capital Management LLC | 1,953,706 | $61.0M | 0.91% | −18,087−0.9% | Reduced |
| Avoro Capital Advisors LLC | 2,525,555 | $78.8M | 1.18% | +1,450,555+134.9% | Added |
| Sands Capital Ventures, LLC | 2,748,970 | $85.8M | 23.49% | −400,000−12.7% | Reduced |
| BlackRock Inc. | 3,052,102 | $95.2M | 0.00% | +1,145,411+60.1% | Added |
| Price T Rowe Associates Inc | 3,219,960 | $100.5M | 0.02% | +666,503+26.1% | Added |
| Northpond Ventures, LLC | 3,292,871 | $102.7M | 55.73% | 00.0% | Unchanged |
| FMR LLC | 5,197,357 | $162.2M | 0.02% | +1,774,433+51.8% | Added |
| Ra Capital Management, L.P. | 6,848,911 | $213.7M | 4.33% | +1,640,000+31.5% | Added |
| Miller Investment Management, LP | 0 | $0 | 0.00% | −180,901−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −152,913−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −97,838−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −71,779−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −15,842−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −15,352−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −13,871−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −11,177−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −6,588−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −325−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −30−100.0% | Sold out |